<SEC-DOCUMENT>0001181431-12-009832.txt : 20120217
<SEC-HEADER>0001181431-12-009832.hdr.sgml : 20120217
<ACCEPTANCE-DATETIME>20120217131609
ACCESSION NUMBER:		0001181431-12-009832
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20120213
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20120217
DATE AS OF CHANGE:		20120217

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CRYO CELL INTERNATIONAL INC
		CENTRAL INDEX KEY:			0000862692
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-SERVICES, NEC [8900]
		IRS NUMBER:				223023093
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1130

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-23386
		FILM NUMBER:		12621838

	BUSINESS ADDRESS:	
		STREET 1:		3165 MCMULLEN BOOTH RD
		STREET 2:		BLDG B
		CITY:			CLEARWATER
		STATE:			FL
		ZIP:			33761
		BUSINESS PHONE:		7277230333

	MAIL ADDRESS:	
		STREET 1:		3165 MCMULLEN BOOTH RD
		STREET 2:		BLDG. B
		CITY:			CLEARWATER
		STATE:			FL
		ZIP:			33761
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>rrd334910.htm
<TEXT>
<HTML>
<HEAD>
<TITLE>Form 8-K Repurchase and Terminate Revenue Sharing (12 12 11) (00129428).DOC</TITLE>
<META NAME="subject" CONTENT="Clients/1276/00129428.DOC/ /font=8">
</HEAD>
<BODY>
<B><P ALIGN="CENTER">UNITED STATES</P>
<P ALIGN="CENTER">SECURITIES AND EXCHANGE COMMISSION</P>
<P ALIGN="CENTER">WASHINGTON, D.C. 20549</P>
<FONT SIZE=4><P ALIGN="CENTER">FORM 8-K</P>
</FONT><P ALIGN="CENTER">CURRENT REPORT</P>
</B><P ALIGN="CENTER">PURSUANT TO SECTION 13 OR 15(D) OF</P>
<P ALIGN="CENTER">THE SECURITIES EXCHANGE ACT OF 1934</P>
<P ALIGN="CENTER">Date of Report (Date of earliest event reported): <U>February 13, 2012</P>
<P ALIGN="CENTER">CRYO-CELL International, Inc.</P>
</U><FONT SIZE=1><P ALIGN="CENTER">(Exact Name of Registrant as Specified in its Charter)</P></FONT>
<P ALIGN="CENTER"><CENTER><TABLE CELLSPACING=0 BORDER=0 CELLPADDING=7 WIDTH=624 DIR="LTR">
<TR><TD WIDTH="31%" VALIGN="BOTTOM">
<U><P ALIGN="CENTER">Delaware</U></TD>
<TD WIDTH="4%" VALIGN="TOP">
<P>&nbsp;</TD>
<TD WIDTH="31%" VALIGN="BOTTOM">
<U><P ALIGN="CENTER">000-23386</U></TD>
<TD WIDTH="4%" VALIGN="TOP">
<P>&nbsp;</TD>
<TD WIDTH="30%" VALIGN="BOTTOM">
<U><P ALIGN="CENTER">22-3023093</U></TD>
</TR>
<TR><TD WIDTH="31%" VALIGN="TOP">
<P ALIGN="CENTER">(State or Other Jurisdiction</P>
<P ALIGN="CENTER">of Incorporation)</TD>
<TD WIDTH="4%" VALIGN="TOP">
<P>&nbsp;</TD>
<TD WIDTH="31%" VALIGN="TOP">
<P ALIGN="CENTER">(Commission File No.)</TD>
<TD WIDTH="4%" VALIGN="TOP">
<P>&nbsp;</TD>
<TD WIDTH="30%" VALIGN="TOP">
<P ALIGN="CENTER">(I.R.S. Employer</P>
<P ALIGN="CENTER">Identification No.)</TD>
</TR>
</TABLE>
</CENTER></P>
<P ALIGN="CENTER"></P>
<P ALIGN="CENTER"><CENTER><TABLE CELLSPACING=0 BORDER=0 CELLPADDING=7 WIDTH=624 DIR="LTR">
<TR><TD WIDTH="65%" VALIGN="BOTTOM">
<U><P>700 Brooker Creek Boulevard, Oldsmar, Florida</U></TD>
<TD WIDTH="4%" VALIGN="TOP">
<P>&nbsp;</TD>
<TD WIDTH="31%" VALIGN="BOTTOM">
<U><P ALIGN="CENTER">34677</U></TD>
</TR>
<TR><TD WIDTH="65%" VALIGN="BOTTOM">
<P>(Address of Principal Executive Offices)</TD>
<TD WIDTH="4%" VALIGN="TOP">
<P>&nbsp;</TD>
<TD WIDTH="31%" VALIGN="BOTTOM">
<P ALIGN="CENTER">(Zip Code)</TD>
</TR>
</TABLE>
</CENTER></P>
<P>Registrant's telephone number, including area code: (813) 749-2100</P>
<U><P ALIGN="CENTER">Not Applicable</P>
</U><FONT SIZE=1><P ALIGN="CENTER">(Former name or former address, if changed since last report)</P>
</FONT><P>Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</P>
<P>[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</P>
<P>[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</P>
<P>[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</P>
<P>[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</P>
<B><P>Item 5.02 Compensatory Arrangements of Certain Officers.</P>
</B><P ALIGN="JUSTIFY">&#9;On February 13, 2012, the Board of Directors of Cryo-Cell International, Inc. (the &quot;Company&quot;) approved amendments to each of the (i) Employment Agreement with David Portnoy dated December 1, 2011 and (ii) Employment Agreement with Mark Portnoy dated December 1, 2011, (collectively, the &quot;Employment Agreements&quot;).</P>
<P ALIGN="JUSTIFY">&#9;The amendment to the Employment Agreement with Mr. David Portnoy (the &quot;David Portnoy Amendment&quot;) and the amendment to the Employment Agreement with Mr. Mark Portnoy (the &quot;Mark Portnoy Amendment&quot;) amend the Employment Agreements to clarify that the determination of whether the &quot;Threshold&quot;, &quot;Target&quot;, and &quot;Stretch&quot; performance standards have been achieved with respect to (i) bonuses to be paid under Section 3(b) of the Employment Agreements; and (ii) the grant of the equity awards described in Section 3 (c)(ii) of the Employment Agreements, shall be made without regard to any accounting impact of such awards on the Company's financial statements.  The David Portnoy Amendment to the Employment Agreements also revises Section 3(c)(ii) to correct the Company's fiscal year end date.</P>
<P ALIGN="JUSTIFY">&#9;Descriptions of the Employment Agreements were previously reported in the Company's Current Reports on Form 8-K, which was filed with the Commission on December 7, 2011 and are hereby incorporated by reference.</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<B><P><A NAME="_Toc145842138"><A NAME="_Toc186020402"><A NAME="_Toc145842139"><A NAME="_Toc186020403"><A NAME="_Toc145842142"><A NAME="_Toc186020406"><A NAME="_Toc145842143"><A NAME="_Toc186020407"><A NAME="_Toc145842144"><A NAME="_Toc186020408"><A NAME="_Toc145842145"><A NAME="_Toc186020409"></A></A></A></A></A></A></A></A></A></A></A></A>Item 9.01. Financial Statements and Exhibits.</P></B>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=7 WIDTH=590 DIR="LTR">
<TR><TD WIDTH="9%" VALIGN="TOP">
<P>&nbsp;</TD>
<TD WIDTH="49%" VALIGN="TOP">
<P>Financial Statements of Businesses Acquired.</TD>
<TD WIDTH="42%" VALIGN="TOP">
<P>Not Applicable.</TD>
</TR>
<TR><TD WIDTH="9%" VALIGN="TOP">
<P>&nbsp;</TD>
<TD WIDTH="49%" VALIGN="TOP">
<P>Pro Forma Financial Information</TD>
<TD WIDTH="42%" VALIGN="TOP">
<P>Not Applicable.</TD>
</TR>
<TR><TD WIDTH="9%" VALIGN="TOP">
<P>&nbsp;</TD>
<TD WIDTH="49%" VALIGN="TOP">
<P>Shell Company Transactions</TD>
<TD WIDTH="42%" VALIGN="TOP">
<P>Not Applicable.</TD>
</TR>
<TR><TD WIDTH="9%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="49%" VALIGN="TOP">
<P>Exhibit No.</TD>
<TD WIDTH="42%" VALIGN="TOP">
<P>Description</TD>
</TR>
<TR><TD WIDTH="9%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="49%" VALIGN="TOP">
<P>10.1 (1)</TD>
<TD WIDTH="42%" VALIGN="TOP">
<P>Employment Agreement between the Company and David Portnoy dated December 1, 2011</TD>
</TR>
<TR><TD WIDTH="9%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="49%" VALIGN="TOP">
<P>10.2 (1)</TD>
<TD WIDTH="42%" VALIGN="TOP">
<P>Employment Agreement between the Company and Mark Portnoy dated December 1, 2011</TD>
</TR>
<TR><TD WIDTH="9%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="49%" VALIGN="TOP">
<P>10.3</TD>
<TD WIDTH="42%" VALIGN="TOP">
<P>Amendment Agreement between the Company and David Portnoy dated February 13, 2012</TD>
</TR>
<TR><TD WIDTH="9%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="49%" VALIGN="TOP">
<P>10.4</TD>
<TD WIDTH="42%" VALIGN="TOP">
<P>Amendment Agreement between the Company and Mark Portnoy dated February 13, 2012</TD>
</TR>
<TR><TD WIDTH="9%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="49%" VALIGN="TOP">
<P>(1)</TD>
<TD WIDTH="42%" VALIGN="TOP">
<P>Incorporated by reference to the Company's Current Report on Form 8-K filed December 7, 2011</TD>
</TR>
</TABLE>
<B><P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>SIGNATURES</P>
</B><P>Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.</P>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=7 WIDTH=649 DIR="LTR">
<TR><TD WIDTH="37%" VALIGN="TOP">
<P>&nbsp;</TD>
<TD WIDTH="6%" VALIGN="TOP">
<P>&nbsp;</TD>
<TD WIDTH="57%" VALIGN="TOP">
<P>Cryo-Cell International, Inc.</P>
</TD>
</TR>
<TR><TD WIDTH="37%" VALIGN="TOP">
<P>DATE: February 17, 2012</TD>
<TD WIDTH="6%" VALIGN="TOP">
<P>By:</TD>
<TD WIDTH="57%" VALIGN="TOP">
<U><P>/s/ Jill M. Taymans </U></TD>
</TR>
<TR><TD WIDTH="37%" VALIGN="TOP">
<P>&nbsp;</TD>
<TD WIDTH="6%" VALIGN="TOP">
<P>&nbsp;</TD>
<TD WIDTH="57%" VALIGN="TOP">
<P>Jill M. Taymans</TD>
</TR>
<TR><TD WIDTH="37%" VALIGN="TOP">
<P>&nbsp;</TD>
<TD WIDTH="6%" VALIGN="TOP">
<P>&nbsp;</TD>
<TD WIDTH="57%" VALIGN="TOP">
<P>Vice President, Finance, Chief Financial Officer</TD>
</TR>
</TABLE>
<FONT SIZE=3></FONT></BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>2
<FILENAME>rrd334910_37170.htm
<DESCRIPTION>AMENDMENT AGREEMENT BETWEEN THE COMPANY AND DAVID PORTNOY DATED FEBRUARY 13, 2012
<TEXT>
<HTML>
<HEAD>
<TITLE>First Amendment to D Portnoy Employ Agt (2 9 12) (00156392).DOCX</TITLE>
<META NAME="subject" CONTENT="Clients/1276/00156392.DOCX/ /font=8">
<META NAME="doccomm" CONTENT="DO NOT STAMP">
</HEAD>
<BODY>
<B><P ALIGN="CENTER">FIRST AMENDMENT TO</P>
<P ALIGN="CENTER">CRYO-CELL INTERNATIONAL, INC.</P>
<P ALIGN="CENTER">EMPLOYMENT AGREEMENT FOR</P>
<P ALIGN="CENTER">DAVID PORTNOY</P>
</B><P ALIGN="CENTER"></P>
<P ALIGN="JUSTIFY">&#9;<B>WHEREAS</B>, Cryo-Cell International, Inc. (the &quot;Company&quot;) and David Portnoy, (the &quot;Executive&quot;) entered into an Employment Agreement dated December 1, 2011 (the &quot;Agreement&quot;); and</P>
<P ALIGN="JUSTIFY">&#9;<B>WHEREAS</B>, the Company and the Executive wish to amend the Agreement to clarify that the determination of whether the &quot;Threshold,&quot; &quot;Target,&quot; and &quot;Stretch&quot; performance standards have been achieved with respect to (i) the bonuses to be paid under Section 3(b) of the Agreement; and (ii) the grant of the equity awards described in Section 3(c)(ii) of the Agreement, shall be made without regard to any accounting impact of such awards on the Company's financial statements; and</P>
<P ALIGN="JUSTIFY">&#9;<B>WHEREAS</B>, Section 14(b) of the Agreement provides that the Agreement may be amended by an instrument in writing signed by the Company and the Executive. </P>
<P ALIGN="JUSTIFY">&#9;<B>NOW THEREFORE</B>, the Company and the Executive hereby agree to amend the Agreement as set forth below:</P>
<P ALIGN="JUSTIFY">&#9;1.&#9;The following is added to the end of Section 3(b), effective as of December 1, 2011:</P><DIR>
<DIR>
<P ALIGN="JUSTIFY">&#9;The &quot;Threshold,&quot; &quot;Target,&quot; and &quot;Stretch&quot; standards for Annual Incentives described in this Section 3(b) shall be determined without regard to any accounting impact of such bonuses on the Company's financial statements.</P></DIR>
</DIR>
<P ALIGN="JUSTIFY">&#9;2.&#9;The following is added to the end of Section 3(c)(ii), effective as of December 1, 2011:</P><DIR>
<DIR>
<P ALIGN="JUSTIFY">&#9;The &quot;Threshold,&quot; &quot;Target,&quot; and &quot;Stretch&quot; standards for Annual Incentives described in Section 3(b) above shall be determined without regard to any accounting impact of such bonuses on the Company's financial statements and without regard to the potential grant of stock options described in this Section 3(c)(ii).</P></DIR>
</DIR>
<P ALIGN="JUSTIFY">&#9;3.&#9;The first paragraph of Section 3(c)(ii) is amended to read as follows, effective as of December 1, 2011 (to correct the Company's fiscal year end date):</P><DIR>
<DIR>
<P>&#9;(ii)&#9;In addition to the grant of stock options described above, if the Executive is employed by the Company on November 30, 2013 , then no later than February 28, 2014, the Company shall grant the Executive stock options under the Company's 2012 Stock Plan to acquire an additional 100,000 shares of Company stock for the achievement of each of the three &quot;Stretch&quot; criteria described above for the fiscal year ending November 30, 2013 (up to 300,000 shares if all three Stretch criteria are achieved) with a grant price equal to the fair market value of a share of Company stock on December 1, 2011, with vesting for each achieved Stretch criteria as follows:</P>
</DIR>
</DIR>
<P ALIGN="JUSTIFY">&#9;<B>IN WITNESS WHEREOF</B>, the Company and the Executive have signed this First Amendment on the date set forth below.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;&#9;&#9;&#9;&#9;<B>CRYO-CELL INTERNATIONAL, INC.</P>
</B><P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<U><P ALIGN="JUSTIFY">February 13, 2012</U>&#9;&#9;&#9;<U>By:  /s/ George Gaines</P>
</U><P ALIGN="JUSTIFY">Date&#9;&#9;&#9;&#9;&#9;George Gaines, Chair, Compensation Committee</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">&#9;&#9;&#9;&#9;&#9;<B>EXECUTIVE</P>
</B><P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<U><P ALIGN="JUSTIFY">February 13, 2012&#9;&#9;</U>&#9;<U>/s/ David Portnoy</P>
</U><P ALIGN="JUSTIFY">Date&#9;&#9;&#9;&#9;&#9;David Portnoy</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&nbsp;</P></BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>3
<FILENAME>rrd334910_37171.htm
<DESCRIPTION>AMENDMENT AGREEMENT BETWEEN THE COMPANY AND MARK PORTNOY DATED FEBRUARY 13, 2012
<TEXT>
<HTML>
<HEAD>
<TITLE>First Amendment to M Portnoy Employ Agt (2 9 12) (00156356).DOCX</TITLE>
<META NAME="subject" CONTENT="Clients/1276/00156356.DOCX/ /font=8">
<META NAME="doccomm" CONTENT="DO NOT STAMP">
</HEAD>
<BODY>
<B><P ALIGN="CENTER">FIRST AMENDMENT TO</P>
<P ALIGN="CENTER">CRYO-CELL INTERNATIONAL, INC.</P>
<P ALIGN="CENTER">EMPLOYMENT AGREEMENT FOR</P>
<P ALIGN="CENTER">MARK PORTNOY</P>
</B><P ALIGN="CENTER"></P>
<P ALIGN="JUSTIFY">&#9;<B>WHEREAS</B>, Cryo-Cell International, Inc. (the &quot;Company&quot;) and Mark Portnoy, (the &quot;Executive&quot;) entered into an Employment Agreement dated December 1, 2011 (the &quot;Agreement&quot;); and</P>
<P ALIGN="JUSTIFY">&#9;<B>WHEREAS</B>, the Company and the Executive wish to amend the Agreement to clarify that the determination of whether the &quot;Threshold,&quot; &quot;Target,&quot; and &quot;Stretch&quot; performance standards have been achieved with respect to (i) the bonuses to be paid under Section 3(b) of the Agreement; and (ii) the grant of the equity awards described in Section 3(c)(ii) of the Agreement, shall be made without regard to any accounting impact of such awards on the Company's financial statements; and</P>
<P ALIGN="JUSTIFY">&#9;<B>WHEREAS</B>, Section 14(b) of the Agreement provides that the Agreement may be amended by an instrument in writing signed by the Company and the Executive. </P>
<P ALIGN="JUSTIFY">&#9;<B>NOW THEREFORE</B>, the Company and the Executive hereby agree to amend the Agreement as set forth below:</P>
<P ALIGN="JUSTIFY">&#9;1.&#9;The following is added to the end of Section 3(b), effective as of December 1, 2011:</P><DIR>
<DIR>
<P ALIGN="JUSTIFY">&#9;The &quot;Threshold,&quot; &quot;Target,&quot; and &quot;Stretch&quot; standards for Annual Incentives described in this Section 3(b) shall be determined without regard to any accounting impact of such bonuses on the Company's financial statements.</P></DIR>
</DIR>
<P ALIGN="JUSTIFY">&#9;2.&#9;The following is added to the end of Section 3(c)(ii), effective as of December 1, 2011:</P><DIR>
<DIR>
<P ALIGN="JUSTIFY">&#9;The &quot;Threshold,&quot; &quot;Target,&quot; and &quot;Stretch&quot; standards for Annual Incentives described in Section 3(b) above shall be determined without regard to any accounting impact of such bonuses on the Company's financial statements and without regard to the potential grant of stock options described in this Section 3(c)(ii).</P>
<P ALIGN="JUSTIFY"></P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P ALIGN="JUSTIFY">&nbsp;</P></DIR>
</DIR>
<P ALIGN="JUSTIFY">&#9;<B>IN WITNESS WHEREOF</B>, the Company and the Executive have signed this First Amendment on the date set forth below.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;&#9;&#9;&#9;&#9;<B>CRYO-CELL INTERNATIONAL, INC.</P>
</B><P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<U><P ALIGN="JUSTIFY">February 13, 2012&#9;</U>&#9;&#9;<U>By:  George Gaines</P>
</U><P ALIGN="JUSTIFY">Date&#9;&#9;&#9;&#9;&#9;George Gaines, Chair, Compensation Committee</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">&#9;&#9;&#9;&#9;&#9;<B>EXECUTIVE</P>
</B><P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<U><P ALIGN="JUSTIFY">February 13, 2012&#9;</U>&#9;&#9;<U>/s/ Mark Portnoy</P>
</U><P ALIGN="JUSTIFY">Date&#9;&#9;&#9;&#9;&#9;Mark Portnoy</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&nbsp;</P></BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
